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Abstract. In the current work, we present the methodology for development of an Item
Response Theory model within a non-linear mixed effects framework to characterize the
longitudinal changes of the Movement Disorder Society (sponsored revision) of Uniﬁed
Parkinson’s Disease Rating Scale (MDS–UPDRS) endpoint in Parkinson’s disease (PD). The
data were obtained from Parkinson’s Progression Markers Initiative database and included
163,070 observations up to 48 months from 430 subjects belonging to De Novo PD cohort.
The probability of obtaining a score, reported for each of the items in the questionnaire, was
modeled as a function of the subject’s disability. Initially, a single latent variable model was
explored to characterize the disease progression over time. However, based on the
understanding of the questionnaire set-up and the results of a residuals-based diagnostic
tool, a three latent variable model with a mixture implementation was able to adequately
describe longitudinal changes not only at the total score level but also at each individual item
level. The linear progression rates obtained for the patient-reported items and the non-sided
items were similar, each of which roughly take about 50 months for a typical subject to
progress linearly from the baseline by one standard deviation. However for the sided items, it
was found that the better side deteriorates quicker than the disabled side. This study presents
a framework for analyzing MDS–UPDRS data, which can be adapted to more traditional
UPDRS data collected in PD clinical trials and result in more efﬁcient designs and analyses of
such studies.
KEY WORDS: Parkinson’s disease; Item Response Theory; Movement Disorder Society (sponsored
revision) Uniﬁed Parkinson’s Disease Rating Scale; disease progression.
INTRODUCTION
Parkinson’s disease (PD) is a chronic neurodegenerative
disorder affecting the central nervous system. The pathophysiolog-
ical manifestation associated with the motor deﬁcits in PD is the
progressive loss of dopaminergic neurons of pars compacta of
substantia nigra resulting in a signiﬁcant decrease in the dopamine
levels. Availability of physiological biomarkers or neuroimaging
markers that can give indications about the disease status is one of
essential prerequisites for studying disease progression. However,
lack of such deﬁnitive markers in PD (1) has been a major
challenge in the development of newer therapies. Among a
number of rating scales used for the assessment in PD, the Uniﬁed
Parkinson’s Disease Rating Scale (UPDRS), originally developed
three decades ago, is still the mainstay. The composite score of the
different components of this rating scale reﬂects the severity of the
disease, i.e., higher score is indicative of a more severe disease.
While the original UPDRS emphasized on gradation
between marked and severely disabled patients, more recent
scientiﬁc advances lay emphasis on early prognosis of the
disease and the need for developing therapies for early
intervention and neuroprotection (2). In order to address
this aspect (among others, such as correcting inconsistencies
and resolving ambiguities, etc.), the Movement Disorder
Society (MDS) sponsored a revision of the UPDRS version
to adapt the scale such that it can detect smaller changes in
the disease early and measure milder deﬁcits. Consequently,
the MDS–UPDRS version focuses on a broader but among
the lower ranges in disability (such as differentiation of slight
from mild deﬁcits) rather than differentiating the gradations
in advanced disability (such as severe from marked deﬁcits)
(2). The MDS–UPDRS questionnaire consists of four parts,
namely, non-motor and motor aspects of experiences of daily
living, motor examination, and motor complications. It has a
total of 68 items, among which 2 items are binary, i.e., have
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0/1 responses, and 66 are ordered categorical responses, most
of which are rated between ﬁve categories, ranging from 0
indicating normal or no impairment to 4 indicating severe
impairment, except for one item, BHoehn and Yahr Stage^
which has six categories (2). The two binary items, i.e., with
two potential responses—Byes^/Bno,^ correspond to whether
dyskinesias were present during the examination (item 60)
and if those movements interfered with the ratings (item 61),
the latter being evaluated only for those who answered Byes^
previously.
Traditionally, analyses of PD trials are performed using
the composite score, e.g., Btotal^ UPDRS score (sum of parts
I, II, and III). However, occasionally, only a portion(s) of the
rating scale (e.g., only the motor component of UPDRS
scale), dependent on the speciﬁc range of disease severity of
the patient cohort (3,4), may be used. The ranges in the
resulting scores may therefore vary greatly, making the
comparability across the rating scales difﬁcult and
leveraging/integration of knowledge from multiple sources
cumbersome. Furthermore, treating the total score as contin-
uous may not be appropriate considering it results from
summing up individual answers to questions of varying
difﬁculty and category range.
Item Response Theory (IRT) has been reported to be a
promising approach compared to the classical methods (5) in
the development and validation of tests in patient-reported
outcomes (PRO) research (6,7). It has also been extensively
used in computerized adaptive educational testing applica-
tions (8). IRT is a statistical framework consisting of
mathematical models that describe the relationship between
an individual’s underlying latent (or hidden) variable to the
pattern of responses to the items on the assessment scale and
such a relationship is described by the Item Characteristic
Curves (ICC). The recent application of the IRT methodol-
ogy in Alzheimer’s disease (9–11), where it was shown to be a
more advantageous approach than the traditional analysis of
the composite score because of an improved utilization of the
data at an individual item level, was later applied and further
explored in other disease areas such as multiple sclerosis (12)
and schizophrenia (13)
In this manuscript, we aimed to further the understand-
ing of the disease progression characteristics in PD by
describing the longitudinal changes in the MDS–UPDRS
data using the IRT approach.
Although the questionnaire is designed to diagnose and
evaluate the overall disease status, each subscale of the
questionnaire reﬂects a speciﬁc aspect of the disease, e.g.,
motor and non-motor-related symptoms. Therefore, addi-
tional objectives of this work were to explore whether the
scale items relate to one or several traits (i.e., the utility of
multiple latent variables in the IRT framework) and to
contribute to the development of appropriate diagnostic tools
to assess these modeling considerations.
MATERIAL AND METHODS
Data
The data were obtained from Parkinson’s Progression
Markers Initiative (PPMI) database (http://www.ppmi-
info.org/data) version available as of November 2014. The
observations used in this work consisted of individual item
level MDS–UPDRS records up to 48 months from 423
subjects belonging to the De Novo PD cohort. The subjects
in this cohort corresponded to patients who were diagnosed
with PD for 2 years or less, did not take PD medications (e.g.,
levodopa, dopamine agonists, MAO-B inhibitors, amanta-
dine, etc.) for more than 60 days prior to the baseline visit,
and were not currently on and did not expect to require PD
medications within at least 6 months from the baseline visit.
MDS–UPDRS observations were collected during the visits
every 3 months up to 12 months and every 6 months after
that, up to 48 months. The demographics of this cohort are
listed in Table I and further information about the design
aspects and the inclusion/exclusion criteria can be found at
http://www.ppmi-info.org/wp-content/uploads/2015/01/PPMI-
AM9-NOV-1-2014_clean.pdf. For the motor examination
(part III) of the questionnaire, which considers if the subjects
are receiving medications for treating the symptoms of PD
and their clinical states, only the pre-dose assessments were
included in the dataset. The few individuals who did not have
information of which cohort they belonged to at the baseline
visit (enrollment) were assigned to the cohort determined at
the screening visit (1.5 months before the baseline visit).
Modeling
The IRT modeling approach was used to describe the
relationship between the probability of the subjects’ re-
sponses for each item of MDS–UPDRS assessment and an
unobservable (latent) disease status, termed as Bdisability.^
Overall, the model development using a single latent variable
Table I. Demographics and PD Characteristics of the DeNoPD
Cohort at Baseline Visit
Variable DeNoPD cohort (N = 423)
Age (years)







Black/African American 6 (1)
Asian 8 (2)
Other 18 (4)
Disease duration since diagnosis (months)
Mean (SD) 6.7 (6.5)
Range (0.4, 35.8)
MDS–UPDRS scores—mean (SD)
Total score 32.4 (13.1)
Part I 5.6 (4.1)
Part II 5.9 (4.2)






consisted of two components: (i) estimation of ICC parame-
ters, discussed below, and (ii) characterization of the longitu-
dinal changes in the Bdisability^ as a consequence of disease
progression.
Item Response Probabilistic Model
The item response model parameters were classiﬁed into
item-speciﬁc parameters namely, aj, bj (described in detail
below) for an item j and subject (denoted i)-speciﬁc
parameter—Bdisability,^ Di. The probability that the subjects’
response was at least k (ranging between 0 and maximum of
K), i.e., the cumulative probability, was modeled using a
proportional odds, ordered categorical model, also referred to
as 2PL (2 parameter logit) in the IRT literature (14). The
functions used to characterize the ICC relationships and the
probability of observing each individual score k, up to a
maximum of K (i.e., either 4 or 5) were calculated by:
P Yi j≥k
  ¼ e
a j Di−b jkð Þ
1þ ea j Di−b jkð Þ
P Yi j ¼ 0
  ¼ 1− P Yi j≥1
 
P Yi j ¼ k
  ¼ P Yi j≥k
 
−P Yi j≥kþ 1
 
P Yi j ¼ K





where Yij is the subjects’ observed response to ith item with a
response of at least k, aj is the slope or discrimination
parameter, and bjk is the difﬁculty parameter, representing
the disability at which there is a 50% probability of obtaining
a positive response for that item. The initial estimates for the
difﬁculty parameter (at individual category level) were
constrained (i) to be non-decreasing for the higher score
categories within each item (i.e., bj,k+1≥ bj,k); (ii) to an upper
bound of 50 for all the score categories except the ﬁrst (i.e.,
bj,k = 1); and (iii) to a ﬁxed value of 50 for items in which there
was no observed response within a certain category, usually
the higher categories (e.g., bj,k = 3 or 4). The implementation
of the latter two constraints provided numerical stability in
the model building process.
For the binary items, the probability of responding Byes^
(i.e., response of 1) was also modeled as a function of
disability using a 2PL model (14):
P Yi j ¼ 1
  ¼ e
a j Di−b jð Þ
1þ ea j Di−b jð Þ
P Yi j ¼ 0
  ¼ 1−P Yi j ¼ 1
 
where the item-speciﬁc parameters aj and bj are the discriminatory
and difﬁculty parameters, respectively, as described above.
IRT Latent Variable Model
The item-speciﬁc parameters, aj, and bjk, characterizing
the ICCs were modeled as ﬁxed effects, while the subject-
speciﬁc Bdisability^ parameter (Di) was modeled as a random
effect. This Bdisability^ scale is a hypothetical construct; it can
take values between −∞ to +∞ and, at baseline, it was
assumed to follow a normal distribution with a mean of zero
and a variance of 1 (N(0, ω2 = 1)).
When investigating longitudinal changes, the disease progres-
sion was implemented on the disability scale using a linear model
(4) as a function of time since baseline visit:
Di(t) =Di,0 + Slopei× t
where Di,0 is a subject-speciﬁc random effect (θi
baseline+ηbaseline,
assumed to be centered around a typical value of 0 and variance
ﬁxed to 1) characterizing the disability at baseline and Slopei is the
rate of disease progression, also a subject-speciﬁc parameter
modeled through random effects (θi
slope+ ηslope). In order to
facilitate the ﬁxation of variance of disability at baseline (to 1)
while allowing for estimating its correlation with the random effect
on the slope, a transformationwas necessary and it was achieved by
implementing the Cholesky decomposition matrix.
Simultaneous Vs. Sequential Parameter Estimation Processes
The simultaneous approach consisted of a single step in
which the ICCs and the longitudinal changes were estimated
simultaneously. On the other hand, the sequential approach
involved a two-step process. In the ﬁrst step, the dataset was
modiﬁed such that observations at each of the subject’s visits
(i.e., from baseline to each of the scheduled visit) were
treated as though they were of separate individuals and the
ICCs were estimated at baseline as the reference and a shift
(parameter) for the post-baseline distribution of disability. In
the second step, the dataset was reconciled, the ICCs were
ﬁxed to their values obtained in the ﬁrst step, and then, the
longitudinal model parameters were estimated.
Furthermore, eta distributions, namely, t-distribution and
box–cox transformation, were investigated for alternative
distributions of the disability at baseline using the ﬁnal
models obtained from both approaches as means to validate
the assumption of normality.
Model Building and Evaluation
All the analyses were performed using the software
NONMEMversion 7.3 (15). The parameter estimationwas carried
out using second-order conditional estimation with Laplacian
approximation. Model selection between the alternative (nested)
models was based on likelihood ratio test of the obtainedOFVat a
signiﬁcance level of p< 0.05 and akaike information criteria (AIC)
was used for evaluating non-nested models.
The ﬁt obtained based on the model-predicted ICCs for
each item were compared to the ﬁt obtained from a
generalized additive model (GAM) using a cross-validated
cubic spline as a smoothing function in R (16). Additionally,
the ﬁnal models from both the approaches were evaluated
using simulation-based diagnostics comparing the ICCs and
the predicted individual disability estimates to simulate
responses (200 replicates) to the observed responses (see
details in Appendices III and VI).
Further simulation-based diagnostics were performed by
visual predictive checks (VPCs) using PsN tools (17). Monte Carlo
simulations of 200 datasets were generated using the ﬁnal models,
and 95% prediction intervals were obtained around the median,
the 2.5th and the 97.5th percentiles at individual item level (the
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proportion of the subjects within each score category) as well as at
total score level (sum of the scores from all the MDS–UPDRS
assessments) level and compared with the same metrics calculated
from the original data.
The correlations between the item responses were also
explored by calculating the residuals (RES) as described below
RESi j ¼ DVi j−Ei j




P kð Þ  k
Where DVij is the observed response of ith individual for
jth item and Eij is the respective weighted prediction from the
ICCs of individual probabilities (as shown in Fig. 1) calcu-
lated based on the model-predicted disability (Di) of each
subject. The correlation matrix of residuals across the items
was then plotted (Fig. 2), with correlation values ranging from
−1 (indicated by blue color) to +1 (indicated by red).
Single Vs. Multiple Latent Variable(s)
The pattern of correlations observed from the residuals plot
with a single latent variable was quintessential in informing the
model building process in terms of visual diagnostics and formed
the basis for exploringmultiple latent variables and gave insight not
only on the number but also the type(s) of variables. The IRT
model building and evaluation using the multiple latent variables
was performed in an identical manner as described with the single
latent variablemodel.However, based on the results obtained from
the single latent variable, only the simultaneous approach was
explored. Additionally, the linear disease progression was imple-
mented separately on each of the latent variable that was explored.
Four latent variables were tested, one each for (i) PR—for the
items (#1–26) which characterized the Patient-Reported (self-
administered) Responses, (ii) RSR—for the items (# 30, 32, 34,
36, 38, 40, 42, 50, 52, 54, 56) which characterized the Right Side
Responses, (iii) LSR—for the items (# 31, 33, 35, 37, 39, 41, 43, 51,
53, 55, 57) which characterized the Left Side Responses, and (iv)
NSR—for the rest of the items (27–29, 44–49, 58–68) which
characterized theNon-SidedResponses, i.e., neither the left nor the
right side. Furthermore, a three latent variables model with PR,
NSR, and SR—for Sided Responses, a common latent variable for
the items (30–43 and 50–57) that evaluated the right and left sides,
was explored with a mixture model. This was implemented in
NONMEMusing the $MIXTURE subroutine to separate out and
estimate the size (or proportion, as a ﬁxed effect parameter) of the
two subpopulations—one whosemost disabled side initially (i.e., at
baseline) was the right side or the other, whose most disabled side
initially (i.e., at baseline) was the left side. Furthermore, a ﬁxed
effect shift parameter (associated with an exponential eta) was
implemented to reﬂect the lower disability for the items assessing
the initially better side, based on the assignment of the individual to
one of the two subpopulations by the mixture. Lastly, owing to the
ambiguity in the description of the ﬁrst six items, as towhether they
were self-administered (PR) or evaluated by the clinical investiga-
tor, the multiple latent variable models described above were also
tested by re-assigning them to NSR instead of PR.
For the longitudinal changes, all the possible correlations
between random effects, i.e., the distribution of disability at
baseline and the slope of the disease progression for each of
the latent variable, were investigated while implementing the
Cholesky decomposition matrix as mentioned above.
RESULTS
Data
Overall, there were 163,070 observations from 430
individuals. The distribution of these responses is shown in
Fig. 3. The ordinal items show a diverse pattern in the
distribution of responses, e.g., items for which the responses
were mostly in the lower score range (2 or less), i.e., skewed
to the left (lower scores suggesting lower disability), which
was the case for majority of the items, as well as a few items
for which responses seemed to be normally distributed. This
pattern of observed responses for the items in MDS–UPDRS
scale in the current dataset is plausible because the subjects
belong to DeNoPD cohort, who had been diagnosed with PD
for 2 years or less at screening. The binary items, since only
recorded by subjects who responded that they had dyskine-
sias (item 60, n = 17 observations) and were further evaluated
if the movements interfered with the ratings (item 61), had, as
expected, very low frequencies of responses. It can also be
observed that items 63 (time spent with dyskinesias) and 64
Fig. 1. Item characteristic curves showing the individual probability of obtaining scores in each category for items 24, 35,
and 62, representative of most informative items within latent variables PR, SR, and NSR, respectively
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(functional impact of dyskinesias), that also rely on item 60,
showed category 0 responses mostly.
Single Latent Variable Model
All the item-speciﬁc parameters were successfully estimated
with both the approaches. However, the simultaneous approach
showed a better OFV value (268,092.95) than the sequential
approach (268,159.99); ﬁnal estimates of the former approach are
provided in Appendix I. Overall, the individual EBE estimates of
the disabilities of the subjects were in the range of −2.73 (healthier
or less disabled) to 3.82 (less healthy or more disabled). When
alternative shapes of distributions, e.g., t-distribution and box–cox
transformation, were explored for the distribution of disability at
baseline, neither theOFV change nor the parameters estimated for
these alternative shapes were found to be signiﬁcant, suggesting
that the normality assumption was valid.
The longitudinal IRT model characterizes the temporal
changes in the Bdisability^ over time. Since it is a hypothetical
construct, it is a dimensionless number, but can be interpreted in
standard deviation terms, i.e., it takes 50 months for a typical
individual to progress linearly (0.02 units/month) by 1 standard
deviation relative to the disability at baseline. Subjects with a lower
disability at baseline were likely to progress faster due to a
correlation of −0.25 between the random effects on baseline and
on slope of disease progression. The goodness of ﬁt plots and
simulation-based diagnostics (provided in Appendices II and III)
suggested that the model was able to adequately characterize the
ICCs and the longitudinal changes in both the total score as well as
the individual item level proﬁles.
The residuals plot (shown in Fig. 2, panel A) showed distinct
patterns, for e.g., positive correlations between residuals of items 1–
26, negative correlations (in general) between residuals of items 1–
26 and 27–43. Furthermore, Bcheckered^ pattern with alternating
positive and negative correlations was observed between the
residuals of items 30–43, and between 30–43 and 50–57, respec-
tively. In order to address these patterns, multiple latent variables
were explored. Another distinct line corresponding to the correla-
tion of the residuals of item61with all the itemswas observed. This,
however, was due to the very low frequency of responses that were
dependent on the responses to item 60.
Multiple Latent Variables
Of the four latent variables (namely PR, RSR, LSR, and
NSR) model and the three latent variables (namely PR, SR,
and NSR) model with a mixture to identify which of the two
subpopulations (most disabled side being either right or left
side) the subject is more likely to belong to, the latter offered a
better description of the data. This choice was driven by the
correlation between the variance of the distribution of disability
at baseline for RSR and LSR being low (−0.15); therefore, a
common latent variable SR seemed a more rational structure.
The ICC parameters of the ﬁnal longitudinal model with three
latent variables and amixture were successfully estimated (listed
in Appendix IV). Owing to the time costs associated with the
current bootstrap techniques together with the model complex-
ity and the data size, standard errors could not be evaluated.
The proportion of subjects whose right side was the most
disabled based on the mixture estimate was 58%. The linear
progression rates of PR and NSR were similar, i.e., around
0.02 units/month, or about 50 months for the typical subject to
progress linearly from the disability at baseline by 1 standard
deviation. However, the progression rates of the SR varied
depending on if the items evaluated the most disabled side
(either the right or the left side) initially (i.e., at baseline) or if
the items evaluated initially the better side.
For the items evaluating the most disabled side initially,
the disease progression occurred slower (slope = 0.0072 units/
month), compared to items evaluating initially the better side
(slope = 0.030 units/month). This suggests that as the initially
better side deteriorates quicker, its difference in disability
with the initially most disabled side becomes smaller as time
progresses. The shift parameter that was used to reﬂect the
lower disability for the initially better side was estimated to
be 2.11 with a SD of 0.60.
The latent variables at baseline were correlated: 0.57 for
PR and NSR, 0.41 for PR and SR, and 0.57 for NSR and SR.
Furthermore, the correlations between the variance of the latent
variable at baseline and the slope of the linear progression of the
same latent variable as well as with the other latent variables
were found to be negative, suggesting that subjects with lower
disability at baseline were likely to progress faster.
Fig. 2. Correlation between the residuals obtained using a single
latent variable IRT model in panel a (top) and a three latent variables
IRT model with mixture in panel b (bottom), across the 68 items of
the score
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The goodness of ﬁt plots for the ﬁnal three latent
variable model with a mixture implementation are shown in
Figs. 4 and 5. The ICCs for the cumulative probabilities for
three items, namely 24 (getting out of bed), 35 (finger tapping
of the left hand), and 62 (Hoen & Yahr stage) representative
of most informative items (as calculated (10) based on Fischer
Information Matrix, FIM) in each of the latent variable
categories, namely PR, SR, and NSR, respectively, shown in
Fig. 4 (and for rest of the items in Appendix V), suggest that
the IRT model ﬁt seems to be in good agreement with the
GAM-cross-validated spline function ﬁt. Additionally, it can
also be observed that the item-speciﬁc parameters, namely
the slope, aj (or discrimination parameter) and the difﬁculty
parameter, bjk, differ between the score categories.
The ICCs for the individual probabilities of the respective
items shown in Fig. 1 seem to overlap. However, the pattern of the
overlap is very different for different items suggesting that the items
vary in the informative content and in their relation to the
(respective) underlying latent variable.
The residuals plot (shown in Fig. 2, panel B) illustrated a
signiﬁcant improvement in the dependence pattern observed
with the single latent variable model. The distinct line corre-
sponding to the correlation of the residuals of item 61 with all
the items was still observed, owing to the very low frequency of
responses that were dependent on the responses on item 60.
Further simulation-based diagnostics are shown in Fig. 5: the
top row and bottom left panels show simulated item responses
belonging to each of the three latent variables, whichwere summed
up to get total score for that respective latent variable and
compared to the respective observed scores, while in the bottom
right panel, all the simulated item responses for items 1 to 68 were
summed up to get the total MDS–UPDRS score and compared to
the total of the observed scores for items 1 to 68, respectively. The
solid lines, representing the median, 2.5th and 97.5th percentiles,
seemed to be within the shaded areas, represented by the 95%
conﬁdence intervals based on themodel prediction, suggesting that
the model simulations were in good agreement with the observa-
tions formost of the time points. The visual predictive checks at the
individual item level are shown in Appendix VII.
DISCUSSION
This work applied IRT methodology to describe the
longitudinal changes in MDS–UPDRS records from the De
Novo Parkinson’s disease patient cohort. To achieve this, it was
necessary to explore the use of multiple latent variables and
development of diagnostic tools to assess it. The questionnaire-
type endpoints are traditionally analyzed using the total
(composite) of sub-scores on a continuous scale. However, the
use of such an analysis method can be potentially limiting or
misleading due to implicit assumptions such as (i) the impor-
tance of the sub-score relative to the total score being ignored,
(ii) the difﬁculty/discrimination between the items in the
questionnaire being ignored, and (iii) ignoring that data may
be missing and that certain subjects may have intentionally
refused to answer an item because it was difﬁcult, thus
Fig. 3. Distributions of observed item responses in the DeNoPD cohort
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incorporating a bias if imputed (e.g., as 0 or mean value). IRT
offers an alternative approach by considering all the individual
item level responses and relating them to an underlying hidden
latent variable, deﬁned as Bdisability^ in this work, while
modeling the longitudinal changes in the disability scale.
This methodology was applied to scales composed of
sub-scores of different types of data, e.g., ordered categorical,
binary, counts. Having its origins in psychometrics and its ﬁrst
pharmacometrics application in Alzheimer’s disease, this
approach has since then been used in schizophrenia, multiple
sclerosis (ms), amyotrophic lateral sclerosis (ALS), and
oncology. In this work, IRT was successfully applied to the
scale MDS–UPDRS used in PD, composed of ordered
categorical and binary items and describing the longitudinal
changes in the disability.
There are two steps while modeling questionnaire data in the
IRT framework: (1) estimation of the item response model
parameters, also referred to as ICCs, and (2) estimation of the
longitudinal aspects of the disease progression. This can be
performed in a sequential or a simultaneous manner. Although
both approaches use the entire data, the way it is handled is slightly
different: in step 1 of the sequential approach, the data is treated
such that each occasion is a separate individual for the estimation of
ICCs, thus efﬁciently utilizing all the information to inform the ICC
parameters. Then, with step 2, the data within each individual was
reconciled, to address the temporal aspects, which are ignored in
step 1, thus potentially avoiding potential misspeciﬁcations. The
simultaneous approach on the other hand aims to capture both
ICCs as well as temporal changes at the same time. In the current
IRTwork, simultaneous ﬁt seemed to give better description of the
data over the sequential ﬁt.
A new diagnostic tool assessing the pattern in residuals
suggested the need to explore multiple latent variables, as a single
latent variablemay not be sufﬁcient to address the different aspects
Fig. 4. Item Characteristic Curve (ICC) ﬁts of the cumulative probabilities along with the generalized additive model
(GAM) diagnostics for items 24, 35, and 62, each representative of most informative items within latent variables PR, SR,
and NSR, respectively. Red dots indicate the observed scores. Panel with B1^ (left most column) shows values with scores 0
and ≥1; panel with B2^ (second column from left) shows values with scores 1 and ≥2; panel with B3^ (third column from left)
shows values with scores 2 and ≥3; panel with B4^ (fourth column from right) shows values with scores 3 and ≥4; panel with
B5^ (last column) shows values with scores of 5. The ICC curves from the IRT model ﬁt (black line) is compared to the ﬁt of
a GAM with cross-validated cubic spline as a smoothing function (dark red line and the associated 95% conﬁdence interval
is shown in gray)
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of the disease. Based on how the questionnaire was set up, a three
latent variable model with a mixture determining whether subjects
were affected predominantly on the left side or the right side was
developed. The model evaluation ﬁts suggested that the model
captured the longitudinal changes adequately. Further, there was a
signiﬁcant improvement in the pattern of the residuals compared to
the obvious patterns observed in the case of the single latent
variable. While not much literature is available where multiple
latent variables were tested within the IRT framework, the
exploratory IRT analysis by Verma et al. (18) reported that
ADAS–cog may not be unidimensional, and explored multiple
latent variables.
In the present work in PD, a mixture was needed on one of
the latent variables. It suggested that there was 58% probability
that a subject belongs to the subpopulation inwhich the right side is
the most likely to be affected.
While a negative correlation was observed between baseline
and slope in the current analysis, a positive correlation has been
reported in the literature when a linear model was used to
characterize longitudinal changes in total score UPDRS data (19).
Plausible explanations for this discrepancy include the difference in
scale (MDS–UPDRS vs. UPDRS) and structural model (IRT vs.
continuous).
Additionally, PD medication (recorded within the following
classes: (a) dopamine replacement, (b) COMT inhibitors, (c)
dopamine agonists, (d) MAO-B inhibitors, (e) propranolol, (f)
anti-cholinergics, and (g) others) was allowed after entry, thus
potentially affecting disease progression. Since the potential effect
of these medications on the disease progression was not quantiﬁed
as part of this study, it must be taken into account in the
interpretation of the disease progression, which is therefore a
combination between true disease progression, placebo effect, and
treatment effect.
One of the promising advantages of the IRT methodol-
ogy is that it allows for pooling of data across multiple studies
and even across the different variants of the assessments.
Therefore, the IRT model developed with MDS–UPDRS
data can be adapted and used as a tool to analyze more
traditional UPDRS data collected in PD clinical trials.
Furthermore, the ICCs generated from this work can be used
as informative priors to analyze PD trial data and thus
effectively integrate knowledge from multiple sources.
CONCLUSION
A longitudinal IRT model with three latent variables was
successfully developed to describe disease progression of PD in
De Novo subjects adequately. This model-based approach
developed using MDS–UPDRS data offers an improved utiliza-
tion ofMDS–UPDRS data, not only at the total score level but at
the individual item level. Additionally, a new diagnostic tool
assessing the pattern of the residuals gave insights into exploring
multiple latent variable models when the single latent variable
modelmay not be appropriate. This framework can be adapted to
handle data from other clinical endpoints in PD and therefore
allowing integration from wide sources.
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